The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurobiology of Disease

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.nbd.2017.05.001PMID 28476637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain

  2015cited by this paper
• Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood–brain barrier and its implications to the transport of neurotoxins

  2015cited by this paper
• Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates

  2015cited by this paper
• Cysteine cathepsins are essential in lysosomal degradation of α-synuclein

  2015cited by this paper
• Decreased Expression of Organic Cation Transporters, Oct1 and Oct2, in Brain Microvessels and its Implication to MPTP-Induced Dopaminergic Toxicity in Aged Mice

  2015cited by this paper
• A Generic Method for Design of Oligomer-Specific Antibodies

  2014cited by this paper
• LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance

  2014cited by this paper
• Macrophages are unsuccessful in clearing aggregated alpha‐synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats

  2013cited by this paper
• Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice

  2013cited by this paper
• α‐Synuclein oligomers and clinical implications for Parkinson disease

  2013cited by this paper
• Mammalian iron transporters: families SLC11 and SLC40.

  2013cited by this paper
• Caudo-rostral brain spreading of α-synuclein through vagal connections

  2013cited by this paper
• Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

  2013cited by this paper
• Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity

  2012cited by this paper
• Age-related Accumulation of Non-heme Ferric and Ferrous Iron in Mouse Ovarian Stroma Visualized by Sensitive Non-heme Iron Histochemistry

  2012cited by this paper
• A Critical Histidine Residue Within LIMP‐2 Mediates pH Sensitive Binding to Its Ligand β‐Glucocerebrosidase

  2012cited by this paper
• Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

  2012cited by this paper
• Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

  2011cited by this paper
• Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity

  2011cited by this paper
• In vivo demonstration that α-synuclein oligomers are toxic

  2011cited by this paper
• Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.

  2010cited by this paper
• Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity.

  2009cited by this paper
• Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.

  2009cited by this paper
• Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

  2008cited by this paper
• Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

  2008cited by this paper
• Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

  2008cited by this paper
• Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

  2008cited by this paper
• Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease

  2008cited by this paper
• Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.

  2008cited by this paper
• Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.

  2008cited by this paper
• Proteome analysis of human substantia nigra in Parkinson's disease

  2008cited by this paper
• Genetic Resistance of Mice to Mycobacterium paratuberculosis Is Influenced by Slc11a1 at the Early but Not at the Late Stage of Infection

  2008cited by this paper
• Evolution of Differences in Transport Function in Slc11a Family Members*

  2007cited by this paper
• Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

  2007cited by this paper
• HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite.

  2007cited by this paper
• Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

  2007cited by this paper
• In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.

  2006cited by this paper
• α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

  2005cited by this paper
• Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

  2005cited by this paper
• Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.

  2005cited by this paper
• Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.

  2004cited by this paper
• SLC11 family of H+-coupled metal-ion transporters NRAMP1 and DMT1

  2004cited by this paper
• Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.

  2004cited by this paper
• Poor and protracted myelination as a contributory factor to neurodegenerative disorders.

  2004cited by this paper
• Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

  2004cited by this paper
• Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane.

  2003cited by this paper
• Genetic control of the innate immune response

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.

  2002cited by this paper
• α-Synuclein is phosphorylated in synucleinopathy lesions

  2002cited by this paper
• alpha-Synuclein is phosphorylated in synucleinopathy lesions.

  2002cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease.

  2001cited by this paper
• Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter.

  2001cited by this paper
• Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress

  2001cited by this paper
• Brain iron pathways and their relevance to Parkinson's disease

  2001cited by this paper
• The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity

  2000cited by this paper
• Human NRAMP2/DMT1, Which Mediates Iron Transport across Endosomal Membranes, Is Localized to Late Endosomes and Lysosomes in HEp-2 Cells*

  2000cited by this paper
• The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

  2000cited by this paper
• Sequestration of iron by Lewy bodies in Parkinson’s disease

  2000cited by this paper
• Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

  1999cited by this paper
• α‐Synuclein expression in substantia nigra and cortex in Parkinson's disease

  1999cited by this paper
• Cell‐specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo

  1997cited by this paper
• Natural Resistance to Infection with Intracellular Pathogens: The Nramp1 Protein Is Recruited to the Membrane of the Phagosome

  1997cited by this paper
• Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression

  1994cited by this paper
• A sensitive post-DAB enhancement technique for demonstration of iron in the central nervous system

  1993cited by this paper
• Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.

  1993cited by this paper
• Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence.

  1982cited by this paper
• Inhibition studies of cathepsins A, B, C and D from rat liver lysosomes.

  1971cited by this paper
• Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Author's Personal Copy Role of Post-translational Modifications in Modulating the Structure, Function and Toxicity of A-synuclein: Implications for Parkinson's Disease Pathogenesis an

  year unknowncited by this paper

• Inhibition of SLC11A1-Mediated Lysosomal Iron Accumulation in Microglia Promotes Repair Following White Matter Stroke.

  2026cites this paper
• Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

  2025cites this paper
• The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression

  2025cites this paper
• Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-speci fi c neuronal state

  2022cites this paper
• Neurons and Glia Interplay in α-Synucleinopathies

  2021cites this paper
• Pan-Tissue Aging Clock Genes That Have Intimate Connections with the Immune System and Age-Related Disease

  2021cites this paper
• Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

  2021cites this paper
• Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.

  2020cites this paper
• Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis

  2020cites this paper
• Single-cell sequencing of the human midbrain reveals glial activation and a neuronal state specific to Parkinson's disease

  2020cites this paper
• Alpha-synuclein spreading pathology in Parkinson's disease: the influence of iron and the Rho-kinase inhibitor fasudil

  2020cites this paper
• Nouvelle stratégie de neuroprotection basée sur la chélation conservatrice du fer dans la maladie de Parkinson

  2019cites this paper
• The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System

  2019cites this paper
• Down‐regulation of natural resistance‐associated macrophage protein‐1 (Nramp1) is associated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)/1‐methyl‐4‐phenylpyridinium (MPP+)‐induced α‐synuclein accumulation and neurotoxicity

  2019cites this paper
• Iron as a therapeutic target for Parkinson's disease

  2018influential citation
• Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention

  2018cites this paper
• Eat Prey, Live: Dictyostelium discoideum As a Model for Cell-Autonomous Defenses

  2018cites this paper